Biotech Values

[Tina]

Good morning dew! Here's a few highlights on Cyber knife!

ARAY

This machine is simply amazing! I've seen it first hand and was so excited about what it can do that after seeing how it operated for the first time, I rushed back to my desk and bought several shares for a long term investment. This machine is being used in many medical facilities in the USA and in several other countries (see DD below). It has been so successful that many sites have placed orders for 2nd machines.

DD:

Cyberknife website:
http://www.accuray.com

The CyberKnife® Robotic Radiosurgery System is the world’s first and only commercially available radiosurgery system designed to treat tumors anywhere in the body with sub-millimeter accuracy. Using image guidance technology and computer controlled robotics, the CyberKnife System is designed to continuously track, detect and correct for tumor and patient movement throughout the treatment. Because of its extreme precision, the CyberKnife System does not require invasive head or body frames to stabilize patient movement, vastly increasing the system’s flexibility.

CyberKnife Facts:

* Due to the high rates of recurrence of resected metastatic disease, surgical resection has often been followed by conventional radiotherapy. The CyberKnife® System has the advantage of effectively providing localized post surgical focused radiation treatment without the morbidity caused by conventional radiotherapy.3

* Non-isocentric radiation beam delivery (i.e., beams that do not have to converge on a single point) allows the dose distribution to conform to even irregularly shaped tumors.

* The accuracy of the CyberKnife System has been shown to be sub-millimetric,4 allowing the delivery of large doses while avoiding critical structures.

* Frameless, non-invasive radiosurgery with the CyberKnife System can be delivered in a single fraction or multiple fractions (sessions). This allows the dose to be spread over 2-5 sessions which may reduce the risk of damage to sensitive structures such as the cranial nerves and the eye.

* The safety and efficacy of the CyberKnife System for the treatment of metastatic intracranial lesions is well established. Published reports indicate high rates of tumor control (91%) for intracranial tumor patients with low complication rates.3

* Benign intracranial tumors also can be effectively treated with the CyberKnife System. A 98% tumor control rate and a 74% hearing preservation rate has been reported for 61 acoustic neuroma patients treated with the CyberKnife between 1999 and 2001.5

* Patients with perioptic tumors have responded well to fractionated radiosurgery with the CyberKnife System. High rates of tumor control (94%) and visual function preservation (94%) was reported in a series of 49 patients.6

* pinpoints tumor areas with 1.5 mm accuracy

* cost for each unit approx 4.02 million dollars

Cyberknife Locations in the USA:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=21593616

International Cyberknife locations:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=21593910

Clinical Publications:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=21592384

stockboard:
http://investorshub.advfn.com/boards/board.asp?board_id=9871